Am. J. Respir. Crit. Care Med., Volume 162, Number 6, December 2000, 2330-2336

Identification of Human Lung and Skin Proteins Conjugated with Hexamethylene Diisocyanate In Vitro and In Vivo

ADAM V. WISNEWSKI, RANJANA SRIVASTAVA, CHRISTINA HERICK, LAN XU, RANULFO LEMUS, HILARY CAIN, NADINE M. MAGOSKI, MERYL H. KAROL, KIM BOTTOMLY, and CARRIE A. REDLICH

Departments of Internal Medicine and Immunobiology, Yale University School of Medicine, New Haven, Connecticut; and Department of Environmental and Occupational Health, University of Pittsburgh, Pittsburgh, Pennsylvania

Diiisocyanates are asthma-causing chemicals used in the commercial production of polyurethane. We have previously shown that human lung epithelial cell proteins can become conjugated with hexamethylene diisocyanate (HDI) and may be biologically important in diisocyanate-induced asthma. The objective of this study was to identify specific human lung and skin proteins that become conjugated with diisocyanate after in vitro and in vivo exposure. Following in vitro exposure of human airway epithelial cells (A549), keratin 18, the 78-kD glucose-regulated protein, trans-1,2-dihyrobenzene-1,2-diol dehydrogenase, and actin were identified as prominent diisocyanate-conjugated proteins through use of a combination of immunocytochemical and mass spectrometric techniques. Following in vivo inhalation of an HDI aerosol, keratin 18 was also identified as the predominant diisocyanate-conjugated protein in human endobronchial biopsy samples, whereas albumin was the predominant diisocyanate-conjugated protein in bronchoalveolar lavage fluid. Keratin was also identified as a predominant diisocyanate-conjugated protein in human skin biopsy samples after epicutaneous exposure to liquid-phase HDI, although the major skin diisocyanate-conjugated protein (56-kD) differed from the predominant lung diisocyanate-conjugated keratin (47-kD). The data from this study identify keratin and other proteins as potential "carriers" for diisocyanates in vivo, and suggest that HDI conjugation of these proteins may play a role in the pathogenesis of diisocyanate-induced asthma.

This article has been cited by other articles:

				S. L. Flack, K. W. Fent, L. G. Trelles Gaines, J. M. Thomasen, S. Whittaker, L. M. Ball, and L. A. Nylander-French Quantitative Plasma Biomarker Analysis in HDI Exposure Assessment Ann. Hyg., January 1, 2010; 54(1): 41 - 54. [Abstract] [Full Text] [PDF]

				J. A. J. Vanoirbeek, V. De Vooght, N. Synhaeve, B. Nemery, and P. H. M. Hoet Is Toluene Diamine a Sensitizer and is there Cross-Reactivity between Toluene Diamine and Toluene Diisocyanate? Toxicol. Sci., June 1, 2009; 109(2): 256 - 264. [Abstract] [Full Text] [PDF]

				D. Bello, C. A. Redlich, M. H. Stowe, J. Sparer, S. R. Woskie, R. P. Streicher, H. D. Hosgood, and Y. Liu Skin Exposure to Aliphatic Polyisocyanates in the Auto Body Repair and Refinishing Industry: II. A Quantitative Assessment Ann. Hyg., March 1, 2008; 52(2): 117 - 124. [Abstract] [Full Text] [PDF]

				Y. LIU, D. BELLO, J. A. SPARER, M. H. STOWE, R. J. GORE, S. R. WOSKIE, M. R. CULLEN, and C. A. REDLICH Skin Exposure to Aliphatic Polyisocyanates in the Auto Body Repair and Refinishing Industry: A Qualitative Assessment Ann. Hyg., July 1, 2007; 51(5): 429 - 439. [Abstract] [Full Text] [PDF]

				C. E. Mapp, P. Boschetto, P. Maestrelli, and L. M. Fabbri Occupational Asthma Am. J. Respir. Crit. Care Med., August 1, 2005; 172(3): 280 - 305. [Abstract] [Full Text] [PDF]

				J. Sastre, O. Vandenplas, and H-S. Park Pathogenesis of occupational asthma Eur. Respir. J., August 1, 2003; 22(2): 364 - 373. [Abstract] [Full Text] [PDF]

				C. A. Redlich, A. V. Wisnewski, and T. Gordon Mouse Models of Diisocyanate Asthma Am. J. Respir. Cell Mol. Biol., October 1, 2002; 27(4): 385 - 390. [Full Text] [PDF]

				D. I. Bernstein, A. Cartier, J. Cote, J.-L. Malo, L.-P. Boulet, M. Wanner, J. Milot, J. L'Archeveque, C. Trudeau, and Z. Lummus Diisocyanate Antigen-stimulated Monocyte Chemoattractant Protein-1 Synthesis Has Greater Test Efficiency than Specific Antibodies for Identification of Diisocyanate Asthma Am. J. Respir. Crit. Care Med., August 15, 2002; 166(4): 445 - 450. [Abstract] [Full Text] [PDF]

				D.-H. Nahm, Y. E. Lee, E.-J. Yim, H.-S. Park, H. Yim, Y. Kang, and J.-K. Kim Identification of Cytokeratin 18 as a Bronchial Epithelial Autoantigen Associated with Nonallergic Asthma Am. J. Respir. Crit. Care Med., June 1, 2002; 165(11): 1536 - 1539. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Asthma, Airway Biology, and Allergic Rhinitis in AJRCCM 2000 Am. J. Respir. Crit. Care Med., November 1, 2001; 164(9): 1559 - 1580. [Full Text] [PDF]